Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aggregation and ion transfer induced by tentoxin.

F Heitz, R Jacquier, F Kaddari

    Biophysical Chemistry
    |March 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    High resolution incoherent Thomson scattering diagnostic for the Resonant Antenna Ion Device (RAID) helicon plasmas.

    The Review of scientific instruments·2026
    Same author

    Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2024
    Same author

    Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2023
    Same author

    Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis.

    Annals of oncology : official journal of the European Society for Medical Oncology·2022
    Same author

    Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.

    Archives of gynecology and obstetrics·2022

    Tentoxin, a cyclic tetrapeptide, increases transmembrane current in lipid bilayers by forming pores. These pores result from the stacking of tentoxin aggregates observed at higher concentrations.

    Area of Science:

    • Biophysics
    • Molecular Biology
    • Membrane Transport

    Background:

    • Tentoxin is a cyclic tetrapeptide known for its biological activity.
    • Understanding the interaction of peptides with lipid bilayers is crucial for membrane transport studies.

    Purpose of the Study:

    • To investigate the effect of tentoxin on transmembrane current in lipid bilayers.
    • To elucidate the mechanism by which tentoxin influences membrane permeability.

    Main Methods:

    • Incorporation of tentoxin into artificial lipid bilayers.
    • Measurement of transmembrane electrical current.
    • Conformational analysis using 1H-NMR, infrared, and circular dichroism spectroscopy.
    • Investigation of tentoxin aggregation in chloroform.

    Related Experiment Videos

    Main Results:

    • Tentoxin addition to lipid bilayers induced discrete events of increased transmembrane current.
    • Conformational studies revealed tentoxin aggregation in chloroform at concentrations above 7 X 10(-5) M.
    • Evidence suggests that stacked tentoxin aggregates may form transmembrane pores.

    Conclusions:

    • Tentoxin can alter the permeability of lipid bilayers.
    • The observed increase in transmembrane current is likely mediated by tentoxin-formed pores.
    • Tentoxin aggregation plays a key role in pore formation and membrane interaction.